Clinical Trials Logo

Filter by:
NCT ID: NCT02246621 Active, not recruiting - Breast Cancer Clinical Trials

A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

MONARCH 3
Start date: November 6, 2014
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to evaluate how effective nonsteroidal aromatase inhibitors (NSAI) plus abemaciclib are in postmenopausal women with breast cancer. Participants will be randomized to abemaciclib or placebo in a 2:1 ratio.

NCT ID: NCT02246335 Active, not recruiting - Clinical trials for Femoral Neck Fractures

Hemiarthroplasty Compared to Total Hip Arthroplasty for Displaced Femoral Neck Fractures in the Elderly-elderly

HOPE
Start date: October 2009
Phase: N/A
Study type: Interventional

Total Hip Arthroplasty is equal to or better than Hemiarthroplasty in the treatment of displaced femoral neck fractures in the elderly-elderly

NCT ID: NCT02246127 Completed - Clinical trials for Neuroendocrine Tumors

Efficacy and Safety of Everolimus and (STZ-5FU) Given One Upfront the Other Upon Progression in Advanced Pancreatic Neuroendocrine Tumor (pNET)

SEQTOR
Start date: October 27, 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare STZ vs everolimus as first line treatment for advanced pNET and to elucidate which sequence of streptozotocin (STZ) based chemotherapy and the mammalian Target of Rapamycin (mTOR) inhibitor, everolimus, gives better results in terms of second Progression Free Survival (PFS) in well differentiated and advanced pancreatic NETs.

NCT ID: NCT02245906 Completed - Healthy Clinical Trials

Effect of Brazilian Fruits Peel on Metabolic Regulation and Appetite in Healthy Subjects

BRASIL-MET
Start date: September 2014
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the study was to investigate how Brazilian fruits peel affect acute/postprandial glucose and insulin responses, inflammatory markers, appetite control peptides, antioxidative capacity, as well as subjective appetite ratings (VAS-visual analogue scales) in healthy volunteers. We hypothesize that certain Brazilian fruits peel added to a standardized meal will improve postprandial glucose tolerance and other metabolic biomarkers in healthy volunteers, compared with a similar meal without the corresponding plant materials.

NCT ID: NCT02245165 Completed - Clinical trials for Gastrointestinal Motility Disorder

Nitric Oxide Control of Migrating Motor Complex: L-NMMA Effects in Relation to Receptor Blockades

LNMMA
Start date: June 2013
Phase: Phase 1
Study type: Interventional

The aim is to elucidate how NO works in conjunction with other neurotransmitters to regulate the migrating motility complex (MMC). Twenty-two healthy volunteers should undergo water-perfused antroduodenojejunal manometry during a control period of 4 h, followed by another 4h after a bolus injection of either saline or the NO synthase inhibitor NG-monomethyl-L-arginine (L-NMMA, 10 mg/kg intravenously) with or without atropine (1 mg) or ondansetron (8 mg). Effects on the MMC pattern are determined. Exhaled and rectal NO is monitored throughout the experiments. Effects of L-NMMA on the MMC pattern are analyzed against a background of atropine or ondansetron. Blood samples are drawn for analysis of simultaneous peptide hormone release into the bloodstream. Peptide hormone release will be correlated to the respective motility pattern elicited by LNMMA.

NCT ID: NCT02244632 Completed - Colorectal Neoplasm Clinical Trials

Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer

Start date: September 2014
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose is to characterise the tolerability of Modufolin (arfolitixorin) in combination with 5-FU alone, in combination with 5-FU and Oxaliplatin, in combination with 5-FU and Irinotecan and in combination with 5-FU, Oxaliplatin and Bevacizumab. Another purpose is to investigate 4 doses of Modufolin to identify the best dose for further assessment.

NCT ID: NCT02243956 Completed - Mood Clinical Trials

Effects on Cognitive Functions and Mood of Food Products Rich in Polyphenols

Start date: January 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate effects of a selected food product rich in polyphenol on cognitive performance and mood.

NCT ID: NCT02243865 Completed - Migraine Clinical Trials

Chordate System Prophylactic Migraine Clinical Investigation

Start date: October 2014
Phase: N/A
Study type: Interventional

The purpose of this pilot study is to evaluate the performance of the Chordate System, in terms of the prophylactic effect and tolerability of treatment in patients diagnosed with migraine.

NCT ID: NCT02241564 Completed - Neoplasms Clinical Trials

Malignancies in Transplanted Patients

MALTX
Start date: November 2007
Phase: N/A
Study type: Observational

The aim of the project is to improve the overall treatment and outcome of renal, pancreas or liver transplanted patients who have encountered a malignancy by a structured treatment program for diagnosis and treatment of the malignancy, optimization of the immunosuppressive treatment, follow-up and evaluation of the program.

NCT ID: NCT02241499 Completed - Clinical trials for Adenocarcinoma of the Esophagus or Esophagogastric Junction

Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol.

PALAESTRA
Start date: October 2014
Phase: Phase 2
Study type: Interventional

In this trial, patients with histologically proven adenocarcinoma of the esophagus or esophagogastric junction noneligible for surgery or chemoradiation with curative intent will be included. Primary objective is to determine the rate of improvement in dysphagia after palliative short course hypofractionated radiotherapy (5 x 4 Gy) followed by chemotherapy consisting of oxaliplatin and fluorouracil. The rate of improvement of dysphagia is evaluated by a 5 graded dysphagia score, and a positive change of at least 1 score is considered to be an improvement.